Focus:
News
-
19 August 2019
US researchers develop skin sensors to wirelessly monitor health
Researchers at Stanford University in the US have developed new sensors that can be adhered to the skin for wireless health monitoring.
-
19 August 2019
FDA approves CVRx’s device to treat advanced heart failure
The US Food and Drug Administration (FDA) has approved CVRx’s Barostim Neo System to address symptoms in advanced heart failure patients.
-
16 August 2019
Non-invasive electrical stimulation alters brain tumour blood flow
Application of non-invasive electrical stimulation to the brains of patients with tumours is able to decrease blood flow within the malignant growths, researchers have found.
-
16 August 2019
Researchers develop new portable robotic exosuit
Researchers at Harvard University’s Wyss Institute for Biologically Inspired Engineering have developed a new portable robotic exosuit with the potential to help people with gait impairments.
-
16 August 2019
FDA grants breakthrough status to V-Wave’s interatrial shunt
The US Food and Drug Administration (FDA) has granted breakthrough device designation to V-Wave’s interatrial shunt for the treatment of patients with symptomatic heart failure (HF).
-
15 August 2019
Watchdog calls for break-up of Tobii-Smartbox merger
The UK Competition and Markets Authority (CMA) has called for the dissolution of recently merged med tech firms Tobii and Smartbox.
-
14 August 2019
Intensive blood pressure control may slow dementia progression
Intensive blood pressure control may be crucial for preventing the development of the white matter lesions characteristic of dementia, according to a new study.
-
14 August 2019
Feinstein Institutes studies MyoRegulator to treat spasticity
Feinstein Institutes for Medical Research has trialled a new medical device called MyoRegulator for the non-invasive treatment of spasticity in stroke patients.
-
14 August 2019
Concept Medical receives breakthrough status for MagicTouch PTA
Concept Medical has secured breakthrough device designation from the US Food and Drug Administration (FDA) for its MagicTouch Percutaneous Transluminal Angioplasty (PTA) sirolimus drug-coated balloon (DCB).
-
14 August 2019
Ancora Heart begins enrolment in AccuCinch device trial
Cardiac therapies developer Ancora Heart has started patient enrolment in the CorCinch EU clinical trial of AccuCinch Ventricular Repair System to treat reduced ejection fraction systolic heart failure (HFrEF).